← Back to Clinical Trials
Recruiting NCT06045455

NCT06045455 Multimodal CT Examination in Stroke Mimics Diagnosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06045455
Status Recruiting
Phase
Sponsor University Hospital Ostrava
Condition Stroke Mimics
Study Type OBSERVATIONAL
Enrollment 3,000 participants
Start Date 2023-10-01
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Multimodal brain CTMagnetic resonance imaging (MRI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 3,000 participants in total. It began in 2023-10-01 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed project is a multicentre prospective observational clinical research focused on refining multimodal computer tomography (CT) diagnostics in stroke mimics. The main aim is to accurately identify SM in order to minimize the risk of receiving inappropriate treatment and possible development of complications, which can have a negative impact on the patient´s health. The project includes an analysis of pharmacoeconomic parameters. It will examine saved costs in the case of non-administration of unindicated treatment and it will compare the number of adverse events related to the administration of unindicated treatment in patients diagnosed with SM.

Eligibility Criteria

Inclusion Criteria: \- an acute focal neurological deficit (minimum 1 point on the National Institutes of Health Stroke Scale - NIHSS) within 24 hours from the onset of symptoms Exclusion Criteria: * the last period of normality is unknown prior to multimodal CT examination * the last period of normality is \>24 hours prior to multimodal CT examination * the diagnostic evaluation is incomplete * a final neurologic diagnosis cannot be determined

Contact & Investigator

Central Contact

Jiří Hynčica

✉ jiri.hyncica@fno.cz

📞 0042059737

Principal Investigator

Michal Bar, prof.,MD,PhD

PRINCIPAL INVESTIGATOR

University Hospital Ostrava

Frequently Asked Questions

Who can join the NCT06045455 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke Mimics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06045455 currently recruiting?

Yes, NCT06045455 is actively recruiting participants. Contact the research team at jiri.hyncica@fno.cz for enrollment information.

Where is the NCT06045455 trial being conducted?

This trial is being conducted at Ostrava, Czechia, Ostrava, Czechia, České Budějovice, Czechia.

Who is sponsoring the NCT06045455 clinical trial?

NCT06045455 is sponsored by University Hospital Ostrava. The principal investigator is Michal Bar, prof.,MD,PhD at University Hospital Ostrava. The trial plans to enroll 3,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology